These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38830506)

  • 21. Means of evaluation and protection from doxorubicin-induced cardiotoxicity and hepatotoxicity in rats.
    Salouege I; Ben Ali R; Ben Saïd D; Elkadri N; Kourda N; Lakhal M; Klouz A
    J Cancer Res Ther; 2014; 10(2):274-8. PubMed ID: 25022377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.
    Rea D; Coppola C; Barbieri A; Monti MG; Misso G; Palma G; Bimonte S; Zarone MR; Luciano A; Liccardo D; Maiolino P; Cittadini A; Ciliberto G; Arra C; Maurea N
    In Vivo; 2016; 30(3):279-90. PubMed ID: 27107087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in rats.
    Behnia K; Boroujerdi M
    J Pharm Pharmacol; 1999 Nov; 51(11):1275-82. PubMed ID: 10632085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging of Chemotherapy-Induced Acute Cardiotoxicity with
    McCluskey SP; Haslop A; Coello C; Gunn RN; Tate EW; Southworth R; Plisson C; Long NJ; Wells LA
    J Nucl Med; 2019 Dec; 60(12):1750-1756. PubMed ID: 31147403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat.
    Hole LD; Larsen TH; Fossan KO; Limé F; Schjøtt J
    BMC Pharmacol Toxicol; 2014 May; 15():28. PubMed ID: 24887454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the pharmacokinetics and cardiotoxicity of doxorubicin in rat receiving nilotinib.
    Zhou ZY; Wan LL; Yang QJ; Han YL; Li Y; Yu Q; Guo C; Li X
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):238-44. PubMed ID: 23770382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity.
    Galán-Arriola C; Lobo M; Vílchez-Tschischke JP; López GJ; de Molina-Iracheta A; Pérez-Martínez C; Agüero J; Fernández-Jiménez R; Martín-García A; Oliver E; Villena-Gutierrez R; Pizarro G; Sánchez PL; Fuster V; Sánchez-González J; Ibanez B
    J Am Coll Cardiol; 2019 Feb; 73(7):779-791. PubMed ID: 30784671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
    Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
    Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-weaning protein malnutrition induces myocardial dysfunction associated with oxidative stress and altered calcium handling proteins in adult rats.
    Belchior ACS; Freire-Júnior DD; Da Costa CP; Vassallo DV; Dos Santos L; Padilha AS
    J Physiol Biochem; 2021 May; 77(2):261-272. PubMed ID: 33555533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity.
    Pecoraro M; Del Pizzo M; Marzocco S; Sorrentino R; Ciccarelli M; Iaccarino G; Pinto A; Popolo A
    Toxicol Appl Pharmacol; 2016 Feb; 293():44-52. PubMed ID: 26780402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
    Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
    Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Doxorubicin, Epirubicin, and Liposomal Doxorubicin (Anthracycline) on cardiac function in patients with osteosarcoma and their influencing factors.
    Ding S; Xiong S; Wang X; Zhang C; Chen S; Sun M; Wu C; Zhang X; Wang M; Wang J; Shang X
    Clin Transl Oncol; 2024 Jun; 26(6):1459-1466. PubMed ID: 38329609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxorubicin-Induced Cardiomyopathy in Children.
    Mancilla TR; Iskra B; Aune GJ
    Compr Physiol; 2019 Jun; 9(3):905-931. PubMed ID: 31187890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
    Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
    Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
    Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
    Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling.
    Verheijen M; Schrooders Y; Gmuender H; Nudischer R; Clayton O; Hynes J; Niederer S; Cordes H; Kuepfer L; Kleinjans J; Caiment F
    Toxicol Lett; 2018 Sep; 294():184-192. PubMed ID: 29803840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Metoprolol and Enalapril in the Prevention of Doxorubicin-induced Cardiotoxicity in Lymphoma Patients.
    Georgakopoulos P; Kyriakidis M; Perpinia A; Karavidas A; Zimeras S; Mamalis N; Kouvela M; Charpidou A
    Anticancer Res; 2019 Oct; 39(10):5703-5707. PubMed ID: 31570470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal rat hearts do not display acute cardiotoxicity in response to maternal Doxorubicin treatment.
    Gziri MM; Pokreisz P; De Vos R; Verbeken E; Debiève F; Mertens L; Janssens SP; Amant F
    J Pharmacol Exp Ther; 2013 Sep; 346(3):362-9. PubMed ID: 23792410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice.
    Vandenwijngaert S; Swinnen M; Walravens AS; Beerens M; Gillijns H; Caluwé E; Tainsh RE; Nathan DI; Allen K; Brouckaert P; Bartunek J; Scherrer-Crosbie M; Bloch KD; Bloch DB; Janssens SP; Buys ES
    Antioxid Redox Signal; 2017 Feb; 26(4):153-164. PubMed ID: 27505125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a "European Pediatric Oncology Off-patents Medicines Consortium" trial.
    Krischke M; Hempel G; Völler S; André N; D'Incalci M; Bisogno G; Köpcke W; Borowski M; Herold R; Boddy AV; Boos J
    Cancer Chemother Pharmacol; 2016 Dec; 78(6):1175-1184. PubMed ID: 27770238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.